Navigation Links
Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
Date:9/9/2008

ct ARIUS' proxy solicitation agent, The Laurel Hill Advisory Group, toll-free at 1-888-270-2614.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements in this release include, but are not limited to, ARIUS successfully advancing its new product programs as well as licensing opportunities. These statements are only predictions and actual events or results may differ materially. Factors that could cause such actual events or results expressed or implied by such forward-looking statements to differ materially from any future results expressed or implied by such statements include, but are not limited to: early stage of development; technology and product development; dependence on and management of current and future corporate collaborations; future capital needs; uncertainty of additional funding; no assurance of market acceptance; dependence on proprietary tech
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
2. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
3. ARIUS announces second quarter fiscal 2008 financial results
4. ARIUS presents new findings for anti-cancer antibody programs at AACR
5. ARIUS announces first quarter fiscal 2008 financial results
6. ARIUS 2008 Annual and Special Meeting of Shareholders
7. ARIUS recognized for entrepreneurial excellence
8. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
9. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
10. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
11. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...,theNasdaqStockMarketthattradinginthecompany,scomm...25-NSEwillbefiledwiththe,SecuritiesandExchangeComm...ingonNasdaq,unlessthecompanyfilesanappealtotheNasd...chanappeal,which,willstaythesuspensionanddelisting...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...tday"motionsbytheU.S.BankruptcyCourtfortheDistrict...ledavoluntarypetitionfor,reliefunderChapter11ofthe... , TheordersissuedbytheBankruptcyCourtallowth...apter11proceedings.Inparticular,the,companyreceive...
(Date:11/24/2009)...sia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood...igationalnewdrugapplication(IND)foritsoralinsulinp...eatdiabetes.ThisIND,approvalallowsBiolaxytoinitiat...sordercharacteristicofhighbloodglucoseandpoor,meta...remicro-and,macro-vasculardiseases,lossofvision,ki...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
... of cash right now. But since he (and just about e... latest version of WorkWises manufacturing softwar... provider of enterprise-wide solutions that help m...use of their information assets. The company recen...d to the latest version of its TCM (Time Critical...
...ge health care and engineering technology. With o... UW-Madison, and leading-edge medical equipment co...ed to lead again as the two fields merge more than...long contributed to health care by providing techn...for cancer treatment, the scope of the scientific ...
...ork has received an exclusive advance copy of Nor...thStar Guide to Growth and Venture Capital in Wisc...in companies seeking information about risk capita...have agreed to excerpt their report in four-instal... installment is: , , Angel Investing in Wisconsin...
Other Biology Technology:WorkWise Helps Manufacturers Squeeze Bottom Line 2The Role of Engineering in Health Science and Technology 2The Role of Engineering in Health Science and Technology 3Angel Investing in Wisconsin 2Angel Investing in Wisconsin 3Angel Investing in Wisconsin 4Angel Investing in Wisconsin 5
(Date:11/23/2009)... CORVALLIS, Ore. A string of recent discoveries ...s renewed interest in this multi-purpose nutrient,... who are deficient in it, spurred research and eve...otic." , On issues ranging from the health of yo...d even vulnerability to influenza, vitamin D is no...
(Date:11/23/2009)... A novel approach to classify the gender of six-w...chicks from being killed shortly after birth, acco...rsity of Technology in Germany and his team. Their...der of young birds shows that it is a fast and acc...breeding industry to identify and select female eg...
(Date:11/23/2009)... This release is available in German . , ...strument wouldn,t be a bad thing. It could help to...e to measure. However, it must do so constructivel...al measurement with more than just imagination, ph...ics have formulated a theory of spatial perception...
Breaking Biology News(10 mins):Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Rescuing male turkey chicks 2Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4Disability gov Adds Social Media Tools Disability Resources and a New Design to Complement Information from 22 Federal Agencies 53575 1Disability gov Adds Social Media Tools Disability Resources and a New Design to Complement Information from 22 Federal Agencies 53575 2Disability gov Adds Social Media Tools Disability Resources and a New Design to Complement Information from 22 Federal Agencies 53575 3Innovator 26apos 3Bs Studio launches new forum for Chief Strategy Officers October 26 27 2009 53571 1Innovator 26apos 3Bs Studio launches new forum for Chief Strategy Officers October 26 27 2009 53571 2Innovator 26apos 3Bs Studio launches new forum for Chief Strategy Officers October 26 27 2009 53571 3Featherstone Informatics Group Inc Named Exclusive Vendor for the American College of Cardiologys Practice Based Data Registry Program 53570 1Featherstone Informatics Group Inc Named Exclusive Vendor for the American College of Cardiologys Practice Based Data Registry Program 53570 2
...sistant Investigator, has been named a Pew Scholar...ts. The honor carries an award of $240,000 over fo...e basis of performance during education and traini...tributors in science relevant to human health. The...and innovative approaches, and encourage risk-taki...
...Researchers at the Hebrew University of Jerusalem ...in-delivery system of highly pathogenic bacteria ... new drugs that will be capable of neutralizing th...ot cause infections. Some, however, are pathogenic...e used to deliver toxins (also termed "effectors")...
... -- VaxInnate Corporation announced today that it ...producing seasonal and pandemic influenza vaccines...will participate in the following three BIO 2008 p...Influenza Research and Surveillance: Preparing fo...including Robert Becker, PhD, MBA, VaxInnate,s Vic...
Other Biology News:Julia Zeitlinger named Pew Scholar 2Test of bacteria toxin delivery system could pave way for new antibiotic drugs 2VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week 2
...mid-Based Deletion Machine is based on the simple,...developed by Goryshin and Reznikoff, and by York e...ns and inversions by intramolecular transposition ... plasmid vector. Although most researchers will be...
...romStreptomyces griseolusthat inhibits protein syn...tivity in eukaryote ribosomes. Reported to induce ...cytic leukemia cells, Jurkat cells, ventricular my...intracellular signals and immediate early gene ind...
VersArray Hybridization Chamber from Bio-Rad
...e-of-the-art separation system using the asymmetri...The Eclipse integrates easily with Wyatts multi-an...iDAWN Tristar, as well as the Optilab DSP. The com... distributions of the particles/molecules separate...
Biology Products: